118 related articles for article (PubMed ID: 9839155)
1. Genotoxicity studies with the antiestrogen toremifene.
Williams GM; Ross PM; Jeffrey AM; Karlsson S
Drug Chem Toxicol; 1998 Nov; 21(4):449-76. PubMed ID: 9839155
[TBL] [Abstract][Full Text] [Related]
2. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
[TBL] [Abstract][Full Text] [Related]
3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
4. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
5. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro.
Hemminki K; Widlak P; Hou SM
Carcinogenesis; 1995 Jul; 16(7):1661-4. PubMed ID: 7614704
[TBL] [Abstract][Full Text] [Related]
6. Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats.
Sargent LM; Dragan YP; Sattler C; Bahnub N; Sattler G; Martin P; Cisneros A; Mann J; Thorgeirsson S; Jordan VC; Pitot HC
Carcinogenesis; 1996 May; 17(5):1051-6. PubMed ID: 8640912
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of antiestrogens.
Hirsimäki P; Aaltonen A; Mäntylä E
Breast J; 2002; 8(2):92-6. PubMed ID: 11896754
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity assessment of the novel antitussive agent Benzonatate and its major metabolite.
Teo S; Madraymootoo W; Dakoulas E; Kulkarni R; McKeon M
Mutat Res Genet Toxicol Environ Mutagen; 2018; 829-830():19-25. PubMed ID: 29704989
[TBL] [Abstract][Full Text] [Related]
9. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.
Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM
Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624
[TBL] [Abstract][Full Text] [Related]
10. Oxymetholone: I. Evaluation in a comprehensive battery of genetic toxicology and in vitro transformation assays.
Holden HE; Studwell D; Majeska JB
Toxicol Pathol; 1999; 27(5):501-6. PubMed ID: 10528628
[TBL] [Abstract][Full Text] [Related]
11. Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human P450 cDNAs (MCL-5 cells).
Styles JA; Davies A; Davies R; White IN; Smith LL
Carcinogenesis; 1997 Feb; 18(2):303-13. PubMed ID: 9054622
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity evaluation of sesamin and episesamin.
Hori H; Takayanagi T; Kamada Y; Shimoyoshi S; Ono Y; Kitagawa Y; Shibata H; Nagao M; Fujii W; Sakakibara Y
Mutat Res; 2011 Feb; 719(1-2):21-8. PubMed ID: 20937410
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the genotoxic potential of the natural neurotoxin Tetrodotoxin (TTX) in a battery of in vitro and in vivo genotoxicity assays.
Guzmán A; Fernández de Henestrosa AR; Marín AP; Ho A; Borroto JI; Carasa I; Pritchard L
Mutat Res; 2007 Dec; 634(1-2):14-24. PubMed ID: 17881283
[TBL] [Abstract][Full Text] [Related]
14. Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2003 May; (508):1-280. PubMed ID: 12844193
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic administration of mestranol, tamoxifen, and toremifene on hepatic ploidy in rats.
Dragan YP; Shimel RJ; Bahnub N; Sattler G; Vaughan JR; Jordan VC; Pitot HC
Toxicol Sci; 1998 Jun; 43(2):129-38. PubMed ID: 9710954
[TBL] [Abstract][Full Text] [Related]
16. Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver.
Williams GM; Iatropoulos MJ; Karlsson S
Carcinogenesis; 1997 Nov; 18(11):2247-53. PubMed ID: 9395228
[TBL] [Abstract][Full Text] [Related]
17. Assay-specific genotoxicity of N-nitrosodibenzylamine to the rat liver in vivo.
Schmezer P; Pool BL; Lefevre PA; Callander RD; Ratpan F; Tinwell H; Ashby J
Environ Mol Mutagen; 1990; 15(4):190-7. PubMed ID: 2192883
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the mutagenicity and genotoxicity of Arrabidaea chica Verlot (Bignoneaceae), an Amazon plant with medicinal properties.
dos Santos VC; Longo TB; Garcia AL; Richter MF; Guecheva TN; Henriques JA; Ferraz Ade B; Picada JN
J Toxicol Environ Health A; 2013; 76(6):381-90. PubMed ID: 23557236
[TBL] [Abstract][Full Text] [Related]
19. Toxicology and carcinogenesis studies of pyrogallol (CAS No. 87-66-1) in F344/N rats and B6C3F1/N mice (dermal studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2013 Feb; (574):1-167. PubMed ID: 23518671
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity studies of 2- and 4-Methylimidazole (CAS No. 693-98-1 and 822-36-6) administered in feed to F344/N rats and B6C3F1 mice.
Chan PC;
Toxic Rep Ser; 2004 Apr; (67):1-G12. PubMed ID: 15146214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]